Haemorrhagic septicaemia (HS), an economically important disease of cattle and buffaloes, is caused by Pasteurella multocida (6:B).
This report aims to provide a comprehensive presentation of the global market for Hemorrhagic Septicemia Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemorrhagic Septicemia Vaccines. This report contains market size and forecasts of Hemorrhagic Septicemia Vaccines in global, including the following market information:
Global Hemorrhagic Septicemia Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Hemorrhagic Septicemia Vaccines Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Hemorrhagic Septicemia Vaccines companies in 2022 (%)
The global Hemorrhagic Septicemia Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Oil-adjuvant Vaccines Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Hemorrhagic Septicemia Vaccines include Bio-Labs (PVT) Limited, Brilliant Bio Pharma, C.A. Laboratorios Asociados (CALA), Ceva Santé Animale, Vecol, FATRO, Indian Immunologicals Limited, Institute of Animal Health and Veterinary Biologicals and Institute of Veterinary Preventive Medicine, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hemorrhagic Septicemia Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hemorrhagic Septicemia Vaccines Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Hemorrhagic Septicemia Vaccines Market Segment Percentages, by Type, 2022 (%)
- Oil-adjuvant Vaccines
- Aluminum hydroxide-adjuvant Vaccines
Global Hemorrhagic Septicemia Vaccines Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Hemorrhagic Septicemia Vaccines Market Segment Percentages, by Application, 2022 (%)
- Cattle
- Buffaloes
Global Hemorrhagic Septicemia Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Hemorrhagic Septicemia Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- - US
- - Canada
- - Mexico
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- - Nordic Countries
- - Benelux
- - Rest of Europe
- Asia
- - China
- - Japan
- - South Korea
- - Southeast Asia
- - India
- - Rest of Asia
- South America
- - Brazil
- - Argentina
- - Rest of South America
- Middle East & Africa
- - Turkey
- - Israel
- - Saudi Arabia
- - UAE
- - Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hemorrhagic Septicemia Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Hemorrhagic Septicemia Vaccines revenues share in global market, 2022 (%)
Key companies Hemorrhagic Septicemia Vaccines sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Hemorrhagic Septicemia Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Bio-Labs (PVT) Limited
- Brilliant Bio Pharma
- C.A. Laboratorios Asociados (CALA)
- Ceva Santé Animale
- Vecol
- FATRO
- Indian Immunologicals Limited
- Institute of Animal Health and Veterinary Biologicals
- Institute of Veterinary Preventive Medicine
- Intervac (PVT) Ltd
- LABIOFAM
- Laboratorios Laverlam
- Laboratorios Ovejero
- Limor de Colombia
- National Veterinary Research Institute
- Zoetis
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hemorrhagic Septicemia Vaccines, market overview.
Chapter 2: Global Hemorrhagic Septicemia Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Hemorrhagic Septicemia Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hemorrhagic Septicemia Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Hemorrhagic Septicemia Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
Hemorrhagic Septicemia Vaccines Market, Global Outlook and Forecast 2023-2029
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Hemorrhagic Septicemia Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hemorrhagic Septicemia Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hemorrhagic Septicemia Vaccines Overall Market Size
2.1 Global Hemorrhagic Septicemia Vaccines Market Size: 2022 VS 2029
2.2 Global Hemorrhagic Septicemia Vaccines Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Hemorrhagic Septicemia Vaccines Sales: 2018-2029
3 Company Landscape
3.1 Top Hemorrhagic Septicemia Vaccines Players in Global Market
3.2 Top Global Hemorrhagic Septicemia Vaccines Companies Ranked by Revenue
3.3 Global Hemorrhagic Septicemia Vaccines Revenue by Companies
3.4 Global Hemorrhagic Septicemia Vaccines Sales by Companies
3.5 Global Hemorrhagic Septicemia Vaccines Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Hemorrhagic Septicemia Vaccines Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Hemorrhagic Septicemia Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hemorrhagic Septicemia Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Hemorrhagic Septicemia Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Hemorrhagic Septicemia Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Hemorrhagic Septicemia Vaccines Market Size Markets, 2022 & 2029
4.1.2 Oil-adjuvant Vaccines
4.1.3 Aluminum hydroxide-adjuvant Vaccines
4.2 By Type - Global Hemorrhagic Septicemia Vaccines Revenue & Forecasts
4.2.1 By Type - Global Hemorrhagic Septicemia Vaccines Revenue, 2018-2023
4.2.2 By Type - Global Hemorrhagic Septicemia Vaccines Revenue, 2024-2029
4.2.3 By Type - Global Hemorrhagic Septicemia Vaccines Revenue Market Share, 2018-2029
4.3 By Type - Global Hemorrhagic Septicemia Vaccines Sales & Forecasts
4.3.1 By Type - Global Hemorrhagic Septicemia Vaccines Sales, 2018-2023
4.3.2 By Type - Global Hemorrhagic Septicemia Vaccines Sales, 2024-2029
4.3.3 By Type - Global Hemorrhagic Septicemia Vaccines Sales Market Share, 2018-2029
4.4 By Type - Global Hemorrhagic Septicemia Vaccines Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hemorrhagic Septicemia Vaccines Market Size, 2022 & 2029
5.1.2 Cattle
5.1.3 Buffaloes
5.2 By Application - Global Hemorrhagic Septicemia Vaccines Revenue & Forecasts
5.2.1 By Application - Global Hemorrhagic Septicemia Vaccines Revenue, 2018-2023
5.2.2 By Application - Global Hemorrhagic Septicemia Vaccines Revenue, 2024-2029
5.2.3 By Application - Global Hemorrhagic Septicemia Vaccines Revenue Market Share, 2018-2029
5.3 By Application - Global Hemorrhagic Septicemia Vaccines Sales & Forecasts
5.3.1 By Application - Global Hemorrhagic Septicemia Vaccines Sales, 2018-2023
5.3.2 By Application - Global Hemorrhagic Septicemia Vaccines Sales, 2024-2029
5.3.3 By Application - Global Hemorrhagic Septicemia Vaccines Sales Market Share, 2018-2029
5.4 By Application - Global Hemorrhagic Septicemia Vaccines Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Hemorrhagic Septicemia Vaccines Market Size, 2022 & 2029
6.2 By Region - Global Hemorrhagic Septicemia Vaccines Revenue & Forecasts
6.2.1 By Region - Global Hemorrhagic Septicemia Vaccines Revenue, 2018-2023
6.2.2 By Region - Global Hemorrhagic Septicemia Vaccines Revenue, 2024-2029
6.2.3 By Region - Global Hemorrhagic Septicemia Vaccines Revenue Market Share, 2018-2029
6.3 By Region - Global Hemorrhagic Septicemia Vaccines Sales & Forecasts
6.3.1 By Region - Global Hemorrhagic Septicemia Vaccines Sales, 2018-2023
6.3.2 By Region - Global Hemorrhagic Septicemia Vaccines Sales, 2024-2029
6.3.3 By Region - Global Hemorrhagic Septicemia Vaccines Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Hemorrhagic Septicemia Vaccines Revenue, 2018-2029
6.4.2 By Country - North America Hemorrhagic Septicemia Vaccines Sales, 2018-2029
6.4.3 US Hemorrhagic Septicemia Vaccines Market Size, 2018-2029
6.4.4 Canada Hemorrhagic Septicemia Vaccines Market Size, 2018-2029
6.4.5 Mexico Hemorrhagic Septicemia Vaccines Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Hemorrhagic Septicemia Vaccines Revenue, 2018-2029
6.5.2 By Country - Europe Hemorrhagic Septicemia Vaccines Sales, 2018-2029
6.5.3 Germany Hemorrhagic Septicemia Vaccines Market Size, 2018-2029
6.5.4 France Hemorrhagic Septicemia Vaccines Market Size, 2018-2029
6.5.5 U.K. Hemorrhagic Septicemia Vaccines Market Size, 2018-2029
6.5.6 Italy Hemorrhagic Septicemia Vaccines Market Size, 2018-2029
6.5.7 Russia Hemorrhagic Septicemia Vaccines Market Size, 2018-2029
6.5.8 Nordic Countries Hemorrhagic Septicemia Vaccines Market Size, 2018-2029
6.5.9 Benelux Hemorrhagic Septicemia Vaccines Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Hemorrhagic Septicemia Vaccines Revenue, 2018-2029
6.6.2 By Region - Asia Hemorrhagic Septicemia Vaccines Sales, 2018-2029
6.6.3 China Hemorrhagic Septicemia Vaccines Market Size, 2018-2029
6.6.4 Japan Hemorrhagic Septicemia Vaccines Market Size, 2018-2029
6.6.5 South Korea Hemorrhagic Septicemia Vaccines Market Size, 2018-2029
6.6.6 Southeast Asia Hemorrhagic Septicemia Vaccines Market Size, 2018-2029
6.6.7 India Hemorrhagic Septicemia Vaccines Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Hemorrhagic Septicemia Vaccines Revenue, 2018-2029
6.7.2 By Country - South America Hemorrhagic Septicemia Vaccines Sales, 2018-2029
6.7.3 Brazil Hemorrhagic Septicemia Vaccines Market Size, 2018-2029
6.7.4 Argentina Hemorrhagic Septicemia Vaccines Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Hemorrhagic Septicemia Vaccines Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Hemorrhagic Septicemia Vaccines Sales, 2018-2029
6.8.3 Turkey Hemorrhagic Septicemia Vaccines Market Size, 2018-2029
6.8.4 Israel Hemorrhagic Septicemia Vaccines Market Size, 2018-2029
6.8.5 Saudi Arabia Hemorrhagic Septicemia Vaccines Market Size, 2018-2029
6.8.6 UAE Hemorrhagic Septicemia Vaccines Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Bio-Labs (PVT) Limited
7.1.1 Bio-Labs (PVT) Limited Company Summary
7.1.2 Bio-Labs (PVT) Limited Business Overview
7.1.3 Bio-Labs (PVT) Limited Hemorrhagic Septicemia Vaccines Major Product Offerings
7.1.4 Bio-Labs (PVT) Limited Hemorrhagic Septicemia Vaccines Sales and Revenue in Global (2018-2023)
7.1.5 Bio-Labs (PVT) Limited Key News & Latest Developments
7.2 Brilliant Bio Pharma
7.2.1 Brilliant Bio Pharma Company Summary
7.2.2 Brilliant Bio Pharma Business Overview
7.2.3 Brilliant Bio Pharma Hemorrhagic Septicemia Vaccines Major Product Offerings
7.2.4 Brilliant Bio Pharma Hemorrhagic Septicemia Vaccines Sales and Revenue in Global (2018-2023)
7.2.5 Brilliant Bio Pharma Key News & Latest Developments
7.3 C.A. Laboratorios Asociados (CALA)
7.3.1 C.A. Laboratorios Asociados (CALA) Company Summary
7.3.2 C.A. Laboratorios Asociados (CALA) Business Overview
7.3.3 C.A. Laboratorios Asociados (CALA) Hemorrhagic Septicemia Vaccines Major Product Offerings
7.3.4 C.A. Laboratorios Asociados (CALA) Hemorrhagic Septicemia Vaccines Sales and Revenue in Global (2018-2023)
7.3.5 C.A. Laboratorios Asociados (CALA) Key News & Latest Developments
7.4 Ceva Santé Animale
7.4.1 Ceva Santé Animale Company Summary
7.4.2 Ceva Santé Animale Business Overview
7.4.3 Ceva Santé Animale Hemorrhagic Septicemia Vaccines Major Product Offerings
7.4.4 Ceva Santé Animale Hemorrhagic Septicemia Vaccines Sales and Revenue in Global (2018-2023)
7.4.5 Ceva Santé Animale Key News & Latest Developments
7.5 Vecol
7.5.1 Vecol Company Summary
7.5.2 Vecol Business Overview
7.5.3 Vecol Hemorrhagic Septicemia Vaccines Major Product Offerings
7.5.4 Vecol Hemorrhagic Septicemia Vaccines Sales and Revenue in Global (2018-2023)
7.5.5 Vecol Key News & Latest Developments
7.6 FATRO
7.6.1 FATRO Company Summary
7.6.2 FATRO Business Overview
7.6.3 FATRO Hemorrhagic Septicemia Vaccines Major Product Offerings
7.6.4 FATRO Hemorrhagic Septicemia Vaccines Sales and Revenue in Global (2018-2023)
7.6.5 FATRO Key News & Latest Developments
7.7 Indian Immunologicals Limited
7.7.1 Indian Immunologicals Limited Company Summary
7.7.2 Indian Immunologicals Limited Business Overview
7.7.3 Indian Immunologicals Limited Hemorrhagic Septicemia Vaccines Major Product Offerings
7.7.4 Indian Immunologicals Limited Hemorrhagic Septicemia Vaccines Sales and Revenue in Global (2018-2023)
7.7.5 Indian Immunologicals Limited Key News & Latest Developments
7.8 Institute of Animal Health and Veterinary Biologicals
7.8.1 Institute of Animal Health and Veterinary Biologicals Company Summary
7.8.2 Institute of Animal Health and Veterinary Biologicals Business Overview
7.8.3 Institute of Animal Health and Veterinary Biologicals Hemorrhagic Septicemia Vaccines Major Product Offerings
7.8.4 Institute of Animal Health and Veterinary Biologicals Hemorrhagic Septicemia Vaccines Sales and Revenue in Global (2018-2023)
7.8.5 Institute of Animal Health and Veterinary Biologicals Key News & Latest Developments
7.9 Institute of Veterinary Preventive Medicine
7.9.1 Institute of Veterinary Preventive Medicine Company Summary
7.9.2 Institute of Veterinary Preventive Medicine Business Overview
7.9.3 Institute of Veterinary Preventive Medicine Hemorrhagic Septicemia Vaccines Major Product Offerings
7.9.4 Institute of Veterinary Preventive Medicine Hemorrhagic Septicemia Vaccines Sales and Revenue in Global (2018-2023)
7.9.5 Institute of Veterinary Preventive Medicine Key News & Latest Developments
7.10 Intervac (PVT) Ltd
7.10.1 Intervac (PVT) Ltd Company Summary
7.10.2 Intervac (PVT) Ltd Business Overview
7.10.3 Intervac (PVT) Ltd Hemorrhagic Septicemia Vaccines Major Product Offerings
7.10.4 Intervac (PVT) Ltd Hemorrhagic Septicemia Vaccines Sales and Revenue in Global (2018-2023)
7.10.5 Intervac (PVT) Ltd Key News & Latest Developments
7.11 LABIOFAM
7.11.1 LABIOFAM Company Summary
7.11.2 LABIOFAM Hemorrhagic Septicemia Vaccines Business Overview
7.11.3 LABIOFAM Hemorrhagic Septicemia Vaccines Major Product Offerings
7.11.4 LABIOFAM Hemorrhagic Septicemia Vaccines Sales and Revenue in Global (2018-2023)
7.11.5 LABIOFAM Key News & Latest Developments
7.12 Laboratorios Laverlam
7.12.1 Laboratorios Laverlam Company Summary
7.12.2 Laboratorios Laverlam Hemorrhagic Septicemia Vaccines Business Overview
7.12.3 Laboratorios Laverlam Hemorrhagic Septicemia Vaccines Major Product Offerings
7.12.4 Laboratorios Laverlam Hemorrhagic Septicemia Vaccines Sales and Revenue in Global (2018-2023)
7.12.5 Laboratorios Laverlam Key News & Latest Developments
7.13 Laboratorios Ovejero
7.13.1 Laboratorios Ovejero Company Summary
7.13.2 Laboratorios Ovejero Hemorrhagic Septicemia Vaccines Business Overview
7.13.3 Laboratorios Ovejero Hemorrhagic Septicemia Vaccines Major Product Offerings
7.13.4 Laboratorios Ovejero Hemorrhagic Septicemia Vaccines Sales and Revenue in Global (2018-2023)
7.13.5 Laboratorios Ovejero Key News & Latest Developments
7.14 Limor de Colombia
7.14.1 Limor de Colombia Company Summary
7.14.2 Limor de Colombia Business Overview
7.14.3 Limor de Colombia Hemorrhagic Septicemia Vaccines Major Product Offerings
7.14.4 Limor de Colombia Hemorrhagic Septicemia Vaccines Sales and Revenue in Global (2018-2023)
7.14.5 Limor de Colombia Key News & Latest Developments
7.15 National Veterinary Research Institute
7.15.1 National Veterinary Research Institute Company Summary
7.15.2 National Veterinary Research Institute Business Overview
7.15.3 National Veterinary Research Institute Hemorrhagic Septicemia Vaccines Major Product Offerings
7.15.4 National Veterinary Research Institute Hemorrhagic Septicemia Vaccines Sales and Revenue in Global (2018-2023)
7.15.5 National Veterinary Research Institute Key News & Latest Developments
7.16 Zoetis
7.16.1 Zoetis Company Summary
7.16.2 Zoetis Business Overview
7.16.3 Zoetis Hemorrhagic Septicemia Vaccines Major Product Offerings
7.16.4 Zoetis Hemorrhagic Septicemia Vaccines Sales and Revenue in Global (2018-2023)
7.16.5 Zoetis Key News & Latest Developments
8 Global Hemorrhagic Septicemia Vaccines Production Capacity, Analysis
8.1 Global Hemorrhagic Septicemia Vaccines Production Capacity, 2018-2029
8.2 Hemorrhagic Septicemia Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Hemorrhagic Septicemia Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Hemorrhagic Septicemia Vaccines Supply Chain Analysis
10.1 Hemorrhagic Septicemia Vaccines Industry Value Chain
10.2 Hemorrhagic Septicemia Vaccines Upstream Market
10.3 Hemorrhagic Septicemia Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Hemorrhagic Septicemia Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Hemorrhagic Septicemia Vaccines in Global Market
Table 2. Top Hemorrhagic Septicemia Vaccines Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Hemorrhagic Septicemia Vaccines Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Hemorrhagic Septicemia Vaccines Revenue Share by Companies, 2018-2023
Table 5. Global Hemorrhagic Septicemia Vaccines Sales by Companies, (K Units), 2018-2023
Table 6. Global Hemorrhagic Septicemia Vaccines Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Hemorrhagic Septicemia Vaccines Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Hemorrhagic Septicemia Vaccines Product Type
Table 9. List of Global Tier 1 Hemorrhagic Septicemia Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hemorrhagic Septicemia Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type - Global Hemorrhagic Septicemia Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Hemorrhagic Septicemia Vaccines Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Hemorrhagic Septicemia Vaccines Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Hemorrhagic Septicemia Vaccines Sales (K Units), 2018-2023
Table 15. By Type - Global Hemorrhagic Septicemia Vaccines Sales (K Units), 2024-2029
Table 16. By Application - Global Hemorrhagic Septicemia Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Hemorrhagic Septicemia Vaccines Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Hemorrhagic Septicemia Vaccines Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Hemorrhagic Septicemia Vaccines Sales (K Units), 2018-2023
Table 20. By Application - Global Hemorrhagic Septicemia Vaccines Sales (K Units), 2024-2029
Table 21. By Region - Global Hemorrhagic Septicemia Vaccines Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Hemorrhagic Septicemia Vaccines Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Hemorrhagic Septicemia Vaccines Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Hemorrhagic Septicemia Vaccines Sales (K Units), 2018-2023
Table 25. By Region - Global Hemorrhagic Septicemia Vaccines Sales (K Units), 2024-2029
Table 26. By Country - North America Hemorrhagic Septicemia Vaccines Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Hemorrhagic Septicemia Vaccines Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Hemorrhagic Septicemia Vaccines Sales, (K Units), 2018-2023
Table 29. By Country - North America Hemorrhagic Septicemia Vaccines Sales, (K Units), 2024-2029
Table 30. By Country - Europe Hemorrhagic Septicemia Vaccines Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Hemorrhagic Septicemia Vaccines Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Hemorrhagic Septicemia Vaccines Sales, (K Units), 2018-2023
Table 33. By Country - Europe Hemorrhagic Septicemia Vaccines Sales, (K Units), 2024-2029
Table 34. By Region - Asia Hemorrhagic Septicemia Vaccines Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Hemorrhagic Septicemia Vaccines Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Hemorrhagic Septicemia Vaccines Sales, (K Units), 2018-2023
Table 37. By Region - Asia Hemorrhagic Septicemia Vaccines Sales, (K Units), 2024-2029
Table 38. By Country - South America Hemorrhagic Septicemia Vaccines Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Hemorrhagic Septicemia Vaccines Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Hemorrhagic Septicemia Vaccines Sales, (K Units), 2018-2023
Table 41. By Country - South America Hemorrhagic Septicemia Vaccines Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Hemorrhagic Septicemia Vaccines Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Hemorrhagic Septicemia Vaccines Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Hemorrhagic Septicemia Vaccines Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Hemorrhagic Septicemia Vaccines Sales, (K Units), 2024-2029
Table 46. Bio-Labs (PVT) Limited Company Summary
Table 47. Bio-Labs (PVT) Limited Hemorrhagic Septicemia Vaccines Product Offerings
Table 48. Bio-Labs (PVT) Limited Hemorrhagic Septicemia Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Bio-Labs (PVT) Limited Key News & Latest Developments
Table 50. Brilliant Bio Pharma Company Summary
Table 51. Brilliant Bio Pharma Hemorrhagic Septicemia Vaccines Product Offerings
Table 52. Brilliant Bio Pharma Hemorrhagic Septicemia Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Brilliant Bio Pharma Key News & Latest Developments
Table 54. C.A. Laboratorios Asociados (CALA) Company Summary
Table 55. C.A. Laboratorios Asociados (CALA) Hemorrhagic Septicemia Vaccines Product Offerings
Table 56. C.A. Laboratorios Asociados (CALA) Hemorrhagic Septicemia Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. C.A. Laboratorios Asociados (CALA) Key News & Latest Developments
Table 58. Ceva Santé Animale Company Summary
Table 59. Ceva Santé Animale Hemorrhagic Septicemia Vaccines Product Offerings
Table 60. Ceva Santé Animale Hemorrhagic Septicemia Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Ceva Santé Animale Key News & Latest Developments
Table 62. Vecol Company Summary
Table 63. Vecol Hemorrhagic Septicemia Vaccines Product Offerings
Table 64. Vecol Hemorrhagic Septicemia Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Vecol Key News & Latest Developments
Table 66. FATRO Company Summary
Table 67. FATRO Hemorrhagic Septicemia Vaccines Product Offerings
Table 68. FATRO Hemorrhagic Septicemia Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. FATRO Key News & Latest Developments
Table 70. Indian Immunologicals Limited Company Summary
Table 71. Indian Immunologicals Limited Hemorrhagic Septicemia Vaccines Product Offerings
Table 72. Indian Immunologicals Limited Hemorrhagic Septicemia Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Indian Immunologicals Limited Key News & Latest Developments
Table 74. Institute of Animal Health and Veterinary Biologicals Company Summary
Table 75. Institute of Animal Health and Veterinary Biologicals Hemorrhagic Septicemia Vaccines Product Offerings
Table 76. Institute of Animal Health and Veterinary Biologicals Hemorrhagic Septicemia Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Institute of Animal Health and Veterinary Biologicals Key News & Latest Developments
Table 78. Institute of Veterinary Preventive Medicine Company Summary
Table 79. Institute of Veterinary Preventive Medicine Hemorrhagic Septicemia Vaccines Product Offerings
Table 80. Institute of Veterinary Preventive Medicine Hemorrhagic Septicemia Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Institute of Veterinary Preventive Medicine Key News & Latest Developments
Table 82. Intervac (PVT) Ltd Company Summary
Table 83. Intervac (PVT) Ltd Hemorrhagic Septicemia Vaccines Product Offerings
Table 84. Intervac (PVT) Ltd Hemorrhagic Septicemia Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Intervac (PVT) Ltd Key News & Latest Developments
Table 86. LABIOFAM Company Summary
Table 87. LABIOFAM Hemorrhagic Septicemia Vaccines Product Offerings
Table 88. LABIOFAM Hemorrhagic Septicemia Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. LABIOFAM Key News & Latest Developments
Table 90. Laboratorios Laverlam Company Summary
Table 91. Laboratorios Laverlam Hemorrhagic Septicemia Vaccines Product Offerings
Table 92. Laboratorios Laverlam Hemorrhagic Septicemia Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. Laboratorios Laverlam Key News & Latest Developments
Table 94. Laboratorios Ovejero Company Summary
Table 95. Laboratorios Ovejero Hemorrhagic Septicemia Vaccines Product Offerings
Table 96. Laboratorios Ovejero Hemorrhagic Septicemia Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 97. Laboratorios Ovejero Key News & Latest Developments
Table 98. Limor de Colombia Company Summary
Table 99. Limor de Colombia Hemorrhagic Septicemia Vaccines Product Offerings
Table 100. Limor de Colombia Hemorrhagic Septicemia Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 101. Limor de Colombia Key News & Latest Developments
Table 102. National Veterinary Research Institute Company Summary
Table 103. National Veterinary Research Institute Hemorrhagic Septicemia Vaccines Product Offerings
Table 104. National Veterinary Research Institute Hemorrhagic Septicemia Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 105. National Veterinary Research Institute Key News & Latest Developments
Table 106. Zoetis Company Summary
Table 107. Zoetis Hemorrhagic Septicemia Vaccines Product Offerings
Table 108. Zoetis Hemorrhagic Septicemia Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 109. Zoetis Key News & Latest Developments
Table 110. Hemorrhagic Septicemia Vaccines Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 111. Global Hemorrhagic Septicemia Vaccines Capacity Market Share of Key Manufacturers, 2021-2023
Table 112. Global Hemorrhagic Septicemia Vaccines Production by Region, 2018-2023 (K Units)
Table 113. Global Hemorrhagic Septicemia Vaccines Production by Region, 2024-2029 (K Units)
Table 114. Hemorrhagic Septicemia Vaccines Market Opportunities & Trends in Global Market
Table 115. Hemorrhagic Septicemia Vaccines Market Drivers in Global Market
Table 116. Hemorrhagic Septicemia Vaccines Market Restraints in Global Market
Table 117. Hemorrhagic Septicemia Vaccines Raw Materials
Table 118. Hemorrhagic Septicemia Vaccines Raw Materials Suppliers in Global Market
Table 119. Typical Hemorrhagic Septicemia Vaccines Downstream
Table 120. Hemorrhagic Septicemia Vaccines Downstream Clients in Global Market
Table 121. Hemorrhagic Septicemia Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Hemorrhagic Septicemia Vaccines Segment by Type in 2022
Figure 2. Hemorrhagic Septicemia Vaccines Segment by Application in 2022
Figure 3. Global Hemorrhagic Septicemia Vaccines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Hemorrhagic Septicemia Vaccines Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Hemorrhagic Septicemia Vaccines Revenue, 2018-2029 (US$, Mn)
Figure 7. Hemorrhagic Septicemia Vaccines Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Hemorrhagic Septicemia Vaccines Revenue in 2022
Figure 9. By Type - Global Hemorrhagic Septicemia Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Hemorrhagic Septicemia Vaccines Revenue Market Share, 2018-2029
Figure 11. By Type - Global Hemorrhagic Septicemia Vaccines Sales Market Share, 2018-2029
Figure 12. By Type - Global Hemorrhagic Septicemia Vaccines Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Hemorrhagic Septicemia Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Hemorrhagic Septicemia Vaccines Revenue Market Share, 2018-2029
Figure 15. By Application - Global Hemorrhagic Septicemia Vaccines Sales Market Share, 2018-2029
Figure 16. By Application - Global Hemorrhagic Septicemia Vaccines Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Hemorrhagic Septicemia Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Hemorrhagic Septicemia Vaccines Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Hemorrhagic Septicemia Vaccines Revenue Market Share, 2018-2029
Figure 20. By Region - Global Hemorrhagic Septicemia Vaccines Sales Market Share, 2018-2029
Figure 21. By Country - North America Hemorrhagic Septicemia Vaccines Revenue Market Share, 2018-2029
Figure 22. By Country - North America Hemorrhagic Septicemia Vaccines Sales Market Share, 2018-2029
Figure 23. US Hemorrhagic Septicemia Vaccines Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Hemorrhagic Septicemia Vaccines Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Hemorrhagic Septicemia Vaccines Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Hemorrhagic Septicemia Vaccines Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Hemorrhagic Septicemia Vaccines Sales Market Share, 2018-2029
Figure 28. Germany Hemorrhagic Septicemia Vaccines Revenue, (US$, Mn), 2018-2029
Figure 29. France Hemorrhagic Septicemia Vaccines Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Hemorrhagic Septicemia Vaccines Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Hemorrhagic Septicemia Vaccines Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Hemorrhagic Septicemia Vaccines Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Hemorrhagic Septicemia Vaccines Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Hemorrhagic Septicemia Vaccines Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Hemorrhagic Septicemia Vaccines Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Hemorrhagic Septicemia Vaccines Sales Market Share, 2018-2029
Figure 37. China Hemorrhagic Septicemia Vaccines Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Hemorrhagic Septicemia Vaccines Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Hemorrhagic Septicemia Vaccines Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Hemorrhagic Septicemia Vaccines Revenue, (US$, Mn), 2018-2029
Figure 41. India Hemorrhagic Septicemia Vaccines Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Hemorrhagic Septicemia Vaccines Revenue Market Share, 2018-2029
Figure 43. By Country - South America Hemorrhagic Septicemia Vaccines Sales Market Share, 2018-2029
Figure 44. Brazil Hemorrhagic Septicemia Vaccines Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Hemorrhagic Septicemia Vaccines Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Hemorrhagic Septicemia Vaccines Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Hemorrhagic Septicemia Vaccines Sales Market Share, 2018-2029
Figure 48. Turkey Hemorrhagic Septicemia Vaccines Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Hemorrhagic Septicemia Vaccines Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Hemorrhagic Septicemia Vaccines Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Hemorrhagic Septicemia Vaccines Revenue, (US$, Mn), 2018-2029
Figure 52. Global Hemorrhagic Septicemia Vaccines Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Hemorrhagic Septicemia Vaccines by Region, 2022 VS 2029
Figure 54. Hemorrhagic Septicemia Vaccines Industry Value Chain
Figure 55. Marketing Channels
Global Classical Swine Fever Vaccines Market Research Report 2024
Published: 08-Jan-2024 Price: US 2900 Onwards Pages: 100
It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of The genus Pestivirus of The family Flaviviridae, and is closely related to The viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV).
The global Classical Swine Fever Vaccines market was valued at US$ 154.7 million in 2023 and is anticipa......
Global Tylosin Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 96
According to our LPI (LP Information) latest study, the global Tylosin market size was valued at US$ 674.4 million in 2023. With growing demand in downstream market, the Tylosin is forecast to a readjusted size of US$ 909 million by 2030 with a CAGR of 4.4% during review period.
The research report highlights the growth potential of the global Tylosin market. Tylosin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chai......
Global Animal Parasiticides Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 106
According to our LPI (LP Information) latest study, the global Animal Parasiticides market size was valued at US$ 6898.6 million in 2023. With growing demand in downstream market, the Animal Parasiticides is forecast to a readjusted size of US$ 9363.4 million by 2030 with a CAGR of 4.5% during review period.
The research report highlights the growth potential of the global Animal Parasiticides market. Animal Parasiticides are expected to show stable growth in the future market. However, ......
Global Newcastle Disease Vaccine Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 114
According to our LPI (LP Information) latest study, the global Newcastle Disease Vaccine market size was valued at US$ 308 million in 2023. With growing demand in downstream market, the Newcastle Disease Vaccine is forecast to a readjusted size of US$ 389.8 million by 2030 with a CAGR of 3.4% during review period.
The research report highlights the growth potential of the global Newcastle Disease Vaccine market. Newcastle Disease Vaccine are expected to show stable growth in the future m......
Global Classical Swine Fever Vaccines Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 126
According to our LPI (LP Information) latest study, the global Classical Swine Fever Vaccines market size was valued at US$ 151.4 million in 2023. With growing demand in downstream market, the Classical Swine Fever Vaccines is forecast to a readjusted size of US$ 209.8 million by 2030 with a CAGR of 4.8% during review period.
The research report highlights the growth potential of the global Classical Swine Fever Vaccines market. Classical Swine Fever Vaccines are expected to show stable ......
Global Veterinary Vaccine Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 151
According to our LPI (LP Information) latest study, the global Veterinary Vaccine market size was valued at US$ 10570 million in 2023. With growing demand in downstream market, the Veterinary Vaccine is forecast to a readjusted size of US$ 17200 million by 2030 with a CAGR of 7.2% during review period.
The research report highlights the growth potential of the global Veterinary Vaccine market. Veterinary Vaccine are expected to show stable growth in the future market. However, product di......
Global Foot and Mouth Disease (FMD) Vaccines Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 134
According to our LPI (LP Information) latest study, the global Foot and Mouth Disease (FMD) Vaccines market size was valued at US$ 895.6 million in 2023. With growing demand in downstream market, the Foot and Mouth Disease (FMD) Vaccines is forecast to a readjusted size of US$ 1644.2 million by 2030 with a CAGR of 9.1% during review period.
The research report highlights the growth potential of the global Foot and Mouth Disease (FMD) Vaccines market. Foot and Mouth Disease (FMD) Vaccines......
Global Veterinary Products for Companion Animals Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 109
According to our LPI (LP Information) latest study, the global Veterinary Products for Companion Animals market size was valued at US$ 15190 million in 2023. With growing demand in downstream market, the Veterinary Products for Companion Animals is forecast to a readjusted size of US$ 22710 million by 2030 with a CAGR of 5.9% during review period.
The research report highlights the growth potential of the global Veterinary Products for Companion Animals market. Veterinary Products for Co......
Global Newcastle Disease Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Published: 01-Jan-2024 Price: US 3480 Onwards Pages: 115
According to our (Global Info Research) latest study, the global Newcastle Disease Vaccine market size was valued at USD 323.9 million in 2023 and is forecast to a readjusted size of USD 402.7 million by 2030 with a CAGR of 3.2% during review period.
Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.
Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines s......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
